[AI-assisted design of avian influenza vaccine animal experiments makes progress] November 8th, the University of Cambridge in the UK recently issued a communiqué stating that a new broad-spectrum avian influenza vaccine designed by the university's team with the help of artificial intelligence (AI) has shown protective efficacy against a variety of avian influenza virus mutant strains in animal experiments. The vaccine candidate was jointly developed by the University of Cambridge and its spin-off companies. Researchers collected avian influenza virus genetic sequence data recorded by global surveillance projects, used AI tools to integrate analysis, and designed a series of "superantigens" that contain the common antigenic characteristics of this type of virus.